Clinical Research Directory
Browse clinical research sites, groups, and studies.
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
Sponsor: Endeavor Health
Summary
Condition: Prostate cancer Intervention: Biopsy and inherited risk assessment
Official title: Observational and Prospective Study on the Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy (GenBx)
Key Details
Gender
MALE
Age Range
40 Years - 69 Years
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2021-12-13
Completion Date
2027-12-13
Last Updated
2026-02-27
Healthy Volunteers
No
Conditions
Interventions
Genetic Assessment
The trial is to observe whether inherited risk, including rare pathogenic mutations (RPMs) in several major genes and SNPs-based genetic risk scores (GRS), is correlated with prostate cancer detection rate from diagnostic prostate biopsy.
Locations (1)
NorthShore University HealthSystem
Evanston, Illinois, United States